By the end of 2017, CTS has secured three source plasma partners and continues to seek additional partners in the plasma industry in order to continue to diversify CTS’s revenue stream.
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...